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Paroxysmal nocturnal haemoglobinura is an acquired disorder of the red cell
membrane rendering the cell especially liable to lysis by activated complement.
There may be a single or several clones of sensitive red cells and the disorder
represents a defect at the pluripotential stem cell stage. This is supported by the
findings of leucopenia and thrombocytopenia and the possible progression to
pancytopenia and acute leukaemia.
CASE REPORT
A 69-year-old non insulin dependent diabetic was first diagnosed at age 57. Her
sister was also diabetic and a brother had died from leukaemia. She had initially
been treated with oral hypoglycaemic agents, but because of persistent hyper-
glycaemia had been changed to insulin at age 63. She remained well until shortly
before the present episode, when she developed increasing fatigue, lost 7 lb
weight and had a poor appetite with intermittent abdominal pain. She was pale,
haemoglobin concentration 7 9 g/dl with normocytic normochromic indices,
1 *5% reticulocytes and white cells 3 *0 x 103/mm. Platelet count was normal,
and ESR 23 mm/hour. Urinalysis for blood, and six faecal occult blood examin-
ations were negative. Serum iron was 6 umol/l (normal 9-29), ferritin 16 ug/l
(normal 18-50), and total iron binding capacity 71 umol/l (normal 43-73).
Serum B12, folate and total bilirubin concentrations were normal. Barium enema
andintravenous pyelographywerenormal; gastroscopyrevealed chronicgastritis.
The plasma haptoglobin concentration was low (0 05 g/dl, normal 0-20-1 *44)
and plasma haemoglobin was increased to 0*25 g/dl (normal 0-0-04),
suggesting haemolysis. The direct Coombs' test was negative. Bone marrow
biopsy showed depressed myelopoiesis, a reduced number of megakaryocytes,
and marked erythroid hyperplasia with dyserythropoietic features. Paroxysmal
nocturnal haemoglobinuria was confirmed by a positive Ham's test, and a sucrose
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lysis test. Haematological measurements had been normal on several previous
occasions, but she had noticed occasional episodes of dark urine on walking and
following exertion. Her haemoglobin concentration is now maintained between
8 0 and 9 0 g/dl by transfusion of washed red cells.
Because of the occurrence of her symptomatic haemoglobinuria during a period
of poor diabetic control, Ham's tests and sucrose lysis tests were performed on
red blood cells from a normal subject, cells from this diabetic patient, and cells
from a non-diabetic patient with known paroxysmal nocturnal haemoglobinuria,
using different concentrations ofglucose, (Tables I and 11). There was no additive
effect of hyperglycaemia on haemolysis before or after acidification in either
patient.
TABLE I
Ham's test. Red cells are exposed at 37°C to normal serum, which is then
acidified (pH 6*5- 7 0) for lysis. The inactivated samples were placed at 56IC
for 10-30 minutes to inactivate complement.
Red cellsfrom anormalsubject, from thispatientandfrom anon-diabeticpatient
with paroxysmal nocturnal haemoglobinuria are compared. Each was also
exposed to three concentrations ofglucose.
Red blood Haemolysis
cells tested Acidified Not Not acidified Acidified
inactivated acidified Acidified +glucose +glucose
10 20 40 10 20 40
mmol/l mmol/l
Normal subject 0 5% 0.5% 0Q5% 0% 0% 0% 0% 0% 0%
This patient 1-8% 4-8% 24-5% 5-9% 5.9% 5-9% 26-3% 24-5% 25-1%
Non-diabetic
patient with
paroxysmal
nocturnal
haemo -
globinuria 0 0% 3.0% 15-4% 3P6% 3-6% 3-6% 13.8% 14-3% 13.8%
TABLE II
Sucrose lysis test. Percentage haemolysis in a solution comprising 0-1 ml of
a 50% suspension of washed red blood cells, 0*5 ml, ABO compatible serum
and 0*9% sucrose, 0*9% saline, and 0*9% glucose respectively. Incubated at
37ICfor 30 minutes and centrifuged.
Red blood cells tested Haemolysis
Saline Sucrose Glucose
Normal subject 0*07% 0*46% 0.75%
This patient 0*09% 40*04% 41*94%
Non diabetic patient
with paroxysmal nocturnal haemoglobinuria 0.09% 16-09% 17 78%
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COMMENT
The basic defect in paroxysmal nocturnal haemoglobinuria remains unknown.
The clinical features derive from red cell membrane abnormalities resulting in
lysis of the membrane by complement. Complement may be activated either by
classical or by the alternative pathways, as shown by the sucrose lysis test and
Ham's test respectively. In vivo lysis tends to be precipitated by the acidification
ofthe blood which occurs during sleep and on exercise. The results of the Ham's
test performed in the presence of increasing quantities of glucose, and the
sucrose lysis test in which sucrose was substituted for glucose do notsuggest that
increasing glucose concentration was a factor in precipitation of haemolysis. In
both tests, except on exposure to saline, the diabetic red blood cells showed a
greater percentage of haemolysis than cells from the non-diabetic patient with
paroxysmal nocturnal haemoglobinuria. This is a reflection of the number of
complement sensitive cells produced by the abnormal clone in each individual
and where the patient has received treatment, is adversely related to the number
oftransfused cells present. It isnormal procedure towash cells priortotransfusion
to reduce the amountoftransfused complement thus avoiding a precipitation ofa
further haemolysis.
This patient did not develop symptoms ofparoxysmal nocturnal haemoglobinuria
until three years after the introduction of insulin therapy for her diabetic control.
Previous surgery did not precipitate symptoms, but the retrospective evidence of
low leucocyte counts suggests that the defect may have been present at that
earliertime, although the haemoglobin was notsignificantly reduced. Herplatelet
count remains at the lower limit of normal which reflects the variability of the
disease and the degree of stem cell disorder. Co-existence of paroxysmal
nocturnal haemoglobinuria and diabetes mellitus has not previously been
reported, but the in vitro experiments suggest that elevated glucose levels do not
aggravate the tendency to haemolysis.
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